PetMedix has joined NOAH as an Associate member. Based in Babraham, Cambridge, PetMedix undertakes research and development into monoclonal antibodies for companion animals.
A new survey commissioned by NOAH shows the cost-of-living crisis is impacting on some dog and cat owners’ ability to continue to afford to care for their pets.
NOAH is proud to be supporting a first-time One Health initiative running throughout November.
Argenta has become NOAH’s latest Associate member.